Castleman Hastalığı: Laparoskopik Yaklaşımla Tedavi Edilen Pararenal Alanda Nadir Bir Retroperitoneal Kitle

Year 2020, Volume: 15 Issue: 2, 135 - 138, 12.06.2020

Uygar Miçooğullari , Asım Özayar , Ali Fuat Atmaca

https://doi.org/10.33719/yud.653413

Abstract

Unicentric Castleman Hastalığı (UCD), etiyolojisi bilinmeyen nadir bir hastalıktır. UCD, lokalize lenfoid doku proliferasyonu ve interfoliküler hipervaskülarite ile karakterizedir. Pararenal alanda, diğer tümörleri taklit edebilen nadir görülen bir kitledir. Bu vakada kliniğimizde laparoskopik yaklaşımla tedavi edilen retroperitoneal UCD'yi sunuyoruz.

Keywords

castleman hastalığı , hiyalin vasküler varyantı , benign tümör , laparoskopi

Castleman’s Disease: A Rare Retroperitoneal Mass In The Pararenal Space Treated With Laparoscopic Approach

Abstract

Unicentric Castleman’s Disease (UCD) is a rare disorder with unknown etiology. UCD is characterized by a localized lymphoid tissue proliferation and interfollicular hypervascularity. It is a rarely seen mass in the pararenal space, which can mimic other tumors. In this case, we present a retroperitoneal UCD which is treated with laparoscopic approach in our clinic

Keywords

unicentric castleman’s disease , hyaline vascular variant , benign neoplasm

Thanks

Dear Editor, We are pleased to submit the manuscript entitled “Castleman’s Disease: A Rare Retroperitoneal Mass In The Pararenal Space Treated With Laparoscopic Approach” to be considered for publication in The New Journal of Urology We obeyed universal rules during the study process. Approval was obtained for the research project from the committee of the institution within which the work was undertaken and it conforms to the provisions of the Declaration of Helsinki (as revised in Tokyo 2004). The subjects gave informed consent and patient anonymity was tried be preserved at a maximal degree. The manuscript has not been published or submitted for publication elsewhere. All authors have contributed significantly for preparation of the paper, and all authors are in agreement with the content of the manuscript. Our study does not violate the policies and/or procedures established by the journal. We declare no conflict of interest. Thank you for consideration and allocation of your valuable time. Sincerely, Dr. Uygar Miçooğulları Department of Urology, University of Health Sciences, Tepecik Education and Research Hospital, İzmir, Turkey Yenişehir, Gaziler street No:468, 35020 Konak/İzmir, Turkey Tel: [phone] [e-mail]

References

• Referans 1. Mantas D, Damaskos C, Dailiani P, Samarkos M,Korkolopoulou P. Castleman’s disease of the spleen. ActaChirBelg2016;117:203–8.
• Referans 2. Casper C. The aetiology and management of Castleman diseaseat 50 years: translating pathophysiology to patientcare. Br J Haematol2005;129:3–17.
• Referans 3. Yi Xie, Yi Zhao, Zhi-Gang Ji, Han-Zhong Li, Guang-Hua Liu, Quan-Zhong MaoCastleman's Disease: A Rare Mass in the Pararenal Retroperitoneum that Mimics Other Tumors. Chinise medical journal 2017 ;130-17
• Referans 4. Bracale U, Pacelli F, Milone M, Bracale UM, Sodo M, Merola G, et al. Laparoscopic treatment of abdominal unicentric Castleman’s disease: a case report and literature review. BMC Surg2017;17:38.
• Referans 5. El-Osta HE, Kurzrock R. Castleman’s disease: from basicmechanisms to molecular therapeutics. Oncologist 2011;16:497–511.